Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Artiva Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Essen Biotech
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Chinese PLA General Hospital
Indapta Therapeutics, INC.
Thomas Jefferson University
Chinese PLA General Hospital
Chinese PLA General Hospital
Celgene
M.D. Anderson Cancer Center
Chinese PLA General Hospital
M.D. Anderson Cancer Center
TCR2 Therapeutics
Precision BioSciences, Inc.
GC Cell Corporation
Columbia University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Targazyme, Inc.
Baylor College of Medicine
Maisonneuve-Rosemont Hospital